Literature DB >> 8387955

Advanced gastroduodenal polyposis with ras mutations in a patient with familial adenomatous polyposis.

R D Odze1, P S Quinn, N A Terrault, A A Vivona, M A Ward, Z Cohen, S Gallinger.   

Abstract

Upper gastrointestinal polyps are being recognized with increasing frequency in patients with familial adenomatous polyposis. Duodenal and periampullary adenomas are the most common type and have poorly understood but definite malignant potential. In contrast, the majority of polypoid lesions in the stomach are benign fundic gland polyps. We report a patient with familial adenomatous polyposis who developed dysplasia in a large exophytic hyperplastic gastric tumor that appeared to arise on a background of diffuse fundic gland polyposis and presented with anemia, hypoalbuminemia, and a protein-losing enteropathy. A large periampullary adenoma also was present. Using the polymerase chain reaction with mismatched primers, a GGT to TGT Kras codon 12 mutation was detected within areas of severe dysplasia in the gastric tumor and in the periampullary adenoma. This case serves to further highlight the spectrum of clinical, pathologic, and molecular features of premalignant upper gastrointestinal tract lesions in patients with familial adenomatous polyposis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8387955     DOI: 10.1016/0046-8177(93)90095-x

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  8 in total

1.  Fundic gland polyps: common and occasionally problematic lesions.

Authors:  Susan C Abraham
Journal:  Gastroenterol Hepatol (N Y)       Date:  2010-01

2.  Sporadic fundic gland polyps with epithelial dysplasia : evidence for preferential targeting for mutations in the adenomatous polyposis coli gene.

Authors:  Susan C Abraham; Seun Ja Park; Lilian Mugartegui; Stanley R Hamilton; Tsung-Teh Wu
Journal:  Am J Pathol       Date:  2002-11       Impact factor: 4.307

3.  Protein-losing enteropathy in a patient with familial adenomatous polyposis and advanced colon cancer.

Authors:  Yoshihiko Miyamoto; Naoki Muguruma; Tetsuo Kimura; Koichi Okamoto; Masahiro Sogabe; Hiroshi Miyamoto; Seiya Kohno; Masahiko Nakasono; Hiroshige Hayashi; Yoshimi Bando; Tetsuji Takayama
Journal:  Clin J Gastroenterol       Date:  2016-05-12

4.  Fundic gland polyps in familial adenomatous polyposis: neoplasms with frequent somatic adenomatous polyposis coli gene alterations.

Authors:  S C Abraham; B Nobukawa; F M Giardiello; S R Hamilton; T T Wu
Journal:  Am J Pathol       Date:  2000-09       Impact factor: 4.307

5.  Prevalence of gastric and duodenal polyps and risk factors for duodenal neoplasm in korean patients with familial adenomatous polyposis.

Authors:  So Youn Park; Ji Kon Ryu; Ju Hee Park; Hyuk Yoon; Ji Yeon Kim; Yong Bum Yoon; Jae-Gahb Park; Sang Hyub Lee; Sung-Bum Kang; Ji Won Park; Jae Hwan Oh
Journal:  Gut Liver       Date:  2011-03-16       Impact factor: 4.519

6.  Evidence for adenoma-carcinoma sequence in the duodenum of patients with familial adenomatous polyposis. The Leeds Castle Polyposis Group (Upper Gastrointestinal Committee).

Authors:  A D Spigelman; I C Talbot; C Penna; K P Nugent; R K Phillips; C Costello; J J DeCosse
Journal:  J Clin Pathol       Date:  1994-08       Impact factor: 3.411

Review 7.  Current Management of Benign Epithelial Gastric Polyps.

Authors:  Antonio R Cheesman; David A Greenwald; Shailja C Shah
Journal:  Curr Treat Options Gastroenterol       Date:  2017-12

Review 8.  Proton pump inhibitors and an emerging epidemic of gastric fundic gland polyposis.

Authors:  Hugh-James Freeman
Journal:  World J Gastroenterol       Date:  2008-03-07       Impact factor: 5.742

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.